Aaron J. Kowalski, Ph.D., CEO of Breakthrough T1D, spoke with Managed Healthcare Executive, talks about the possible impacts ...
Layoffs, funding freezes, and executive orders spark outcry among federal researchers and university partners, fearing that science itself is under siege.
The funding agency aims to cap “indirect costs” in biomedical research grants. But this behind-the-scenes work is crucial to making research happen.